Dashboard
Manage Tickers

RCUSArcus Biosciences, Inc.

NYSE arcusbio.com


$ 15.98 $ -0.21 (-1.3 %)    

Tuesday, 18-Jun-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 485.28 $ 0.15 (0.03 %)
DIA $ 389.19 $ 0.56 (0.14 %)
SPY $ 548.51 $ 1.39 (0.25 %)
TLT $ 94.60 $ 0.86 (0.92 %)
GLD $ 215.51 $ 0.86 (0.4 %)
$ 15.99
$ 15.90
$ 0.00 x 0
$ 0.00 x 0
$ 15.36 - $ 16.07
$ 12.95 - $ 25.47
980,892
na
1.38B
$ 1.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-05-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Arcus Biosciences In Collaboration With Gi...
06/10/2024 12:38:47

Domvanalimab is the only anti-TIGIT antibody in Phase 3 for upper gastrointestinal (GI) adenocarcinomas with the potential to b...

after-disappointing-bladder-cancer-data-gilead-announces-encouraging-data-from-gastric-colorectal-cancer-studies
After Disappointing Bladder Cancer Data, G...
06/03/2024 16:35:14

Gilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cance...

citigroup-maintains-buy-on-arcus-biosciences-raises-price-target-to-38
Citigroup Maintains Buy on Arcus Bioscienc...
06/03/2024 15:13:11

Citigroup analyst Yigal Nochomovitz maintains Arcus Biosciences (NYSE:RCUS) with a Buy and raises the price target from $36 ...

Core News & Articles
Gilead And Arcus Announced Etrumadenant Pl...
06/02/2024 14:36:05

Gilead Sciences, Inc. (NASDAQ:GILD) and Arcus Biosciences, Inc. (NYSE:RCUS) today announced new data from Cohort B of ARC-9, a ...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
05/24/2024 12:07:16

wedbush-reiterates-outperform-on-arcus-biosciences-maintains-30-price-target
Wedbush Reiterates Outperform on Arcus Bio...
05/09/2024 12:50:31

Wedbush analyst Robert Driscoll reiterates Arcus Biosciences (NYSE:RCUS) with a Outperform and maintains $30 price target.

arcus-biosciences-q1-2024-gaap-eps-005-beats-098-estimate-sales-145000m-beat-33862m-estimate
Arcus Biosciences Q1 2024 GAAP EPS $(0.05)...
05/08/2024 21:31:37

Arcus Biosciences (NYSE:RCUS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.9...

arcus-biosciences-to-present-new-data-from-phase-2-studies-of-novel-immuno-oncology-combinations-at-2024-asco-annual-meeting
Arcus Biosciences To Present New Data From...
04/24/2024 20:02:16

Updated data from EDGE-Gastric evaluating domvanalimab plus zimberelimab and chemotherapy in upper gastrointestinal (GI) cancer...

navigating-5-analyst-ratings-for-arcus-biosciences
Navigating 5 Analyst Ratings For Arcus Bio...
03/25/2024 16:01:09

truist-securities-reiterates-buy-on-arcus-biosciences-maintains-50-price-target
Truist Securities Reiterates Buy on Arcus ...
03/25/2024 15:54:56

Truist Securities analyst Robyn Karnauskas reiterates Arcus Biosciences (NYSE:RCUS) with a Buy and maintains $50 price target.

critical-insights-from-arcus-biosciences-analyst-ratings-what-you-need-to-know
Critical Insights From Arcus Biosciences A...
02/22/2024 14:00:14

wedbush-reiterates-outperform-on-arcus-biosciences-maintains-30-price-target
Wedbush Reiterates Outperform on Arcus Bio...
02/22/2024 13:23:45

Wedbush analyst Robert Driscoll reiterates Arcus Biosciences (NYSE:RCUS) with a Outperform and maintains $30 price target.

recap-arcus-biosciences-q4-earnings
Recap: Arcus Biosciences Q4 Earnings
02/21/2024 21:30:18

arcus-biosciences-q4-2023-gaap-eps-108-misses-098-estimate-sales-3100m-beat-2837m-estimate
Arcus Biosciences Q4 2023 GAAP EPS $(1.08)...
02/21/2024 21:28:52

Arcus Biosciences (NYSE:RCUS) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0...

earnings-scheduled-for-february-21-2024
Earnings Scheduled For February 21, 2024
02/21/2024 10:09:04

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on...

preview-arcus-biosciencess-earnings
Preview: Arcus Biosciences's Earnings
02/20/2024 19:01:04

320m-bet-on-this-healthcare-stock-check-out-these-3-stocks-insiders-are-buying
$320M Bet On This Healthcare Stock? Check ...
02/01/2024 11:09:28

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

key-takeaways-from-arcus-biosciences-analyst-ratings
Key Takeaways From Arcus Biosciences Analy...
01/30/2024 18:00:19

wedbush-maintains-outperform-on-arcus-biosciences-lowers-price-target-to-30
Wedbush Maintains Outperform on Arcus Bios...
01/30/2024 15:46:26

Wedbush analyst Robert Driscoll maintains Arcus Biosciences (NYSE:RCUS) with a Outperform and lowers the price target from $...

mizuho-maintains-buy-on-arcus-biosciences-lowers-price-target-to-42-report-released-on-29-january-2024
Mizuho Maintains Buy on Arcus Biosciences,...
01/30/2024 14:35:55

Mizuho analyst Mara Goldstein maintains Arcus Biosciences (NYSE:RCUS) with a Buy and lowers the price target from $51 to $42.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)